Przegląd Menopauzalny

Full text

2/2026 vol. 25
Review paper

Beyond the panacea: addressing the systemic failure in midlife female sexual health

  1. Department of Clinical Medicine, Near East University, Nicosia, Cyprus

  2. Department of Obstetrics and Gynaecology, Lothan Hospital, Kuwait City, Kuwait

  3. Department of Population Health Sciences, University of Leicester, Leicester, United Kingdom

Menopause Rev 2026; 25(2): 123-128

Data publikacji online: 2026/09/25
Article file
Beyond the panacea.pdf
  1. Eysenbach G. How five gigabytes of data can change the world of medicine. J Med Internet Res 2001; 3: e20.
  2. Tan SS, Goonawardene N. Internet health information seeking and the patient-physician relationship. J Med Internet Res 2017; 19: e9.
  3. Bachkangi P. Menopause and mental health: clinical evidence and public discourse. Menopause Rev 2026; 25: 1-9.
  4. Kickbusch I, Allen L, Franz C. The commercial determinants of health. Lancet Glob Health 2016; 4: e895-896.
  5. Young J, Song Z. Patients as consumers: empowerment or commodification? Stanford: Stanford Center on Poverty and Inequality; 2017.
  6. Moynihan R, Heath I, Henry D. Selling sickness: the pharmaceutical industry and disease mongering. BMJ 2002; 324: 886-891.
  7. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, et al. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999; 282: 1458-1465.
  8. Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients’ care. Lancet 2003; 362: 1225-1230.
  9. Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, et al. Global Consensus Position Statement on the use of testosterone therapy for women. J Clin Endocrinol Metab 2019; 104: 4660-4666.
  10. Ainsworth C. Testosterone for menopause: why women face difficulties accessing treatment. Pharm J 2023; 310.
  11. Bancroft J, Janssen E. The dual control model of sexual response: a theoretical framework. J Sex Res 2000; 37: 102-112.
  12. Wierman ME, Arlt W, Basson R, Davis SR, Miller KK, Murad MH, et al. Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2014; 99: 3489-3510.
  13. Islam RM, Bell RJ, Green S, Page MJ, Davis SR. Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data. Lancet Diabetes Endocrinol 2019; 7: 754-766.
  14. Stahl SM. Stahl’s essential psychopharmacology: neuroscientific basis and practical applications. 5th ed. Cambridge University Press, Cambridge 2021.
  15. Davis SR. Testosterone for women: certainties and uncertainties. Climacteric 2022; 26: 21-24.
  16. Simon JA, Kapner MD. The saga of testosterone for menopausal women at the Food and Drug Administration. J Sex Med 2020; 17: 826-829.
  17. Buckley M. Androfeme: development and regulatory approval of a female-specific testosterone formulation. Med J Aust 2021; 214: 345-347.
  18. Lee JH, Kim TH, Park HM. Menopause management in Asia: current status and future directions. J Menopausal Med 2020; 26: 1-8.
  19. McGlynn EA, Asch SM, Adams J, Keesey J, Hicks J, DeCristofaro A, et al. The quality of health care delivered to adults in the United States. N Engl J Med 2003; 348: 2635-2645.
  20. Kahneman D. Thinking, fast and slow. Farrar, Straus and Giroux, . New York 2011.
  21. Simon HA. Bounded rationality and organizational learning. Organ Sci 1991; 2: 125-134.
  22. World Medical Association. Statement concerning the relationship between physicians and commercial enterprises. Ferney-Voltaire: World Medical Association; 2019.
  23. Moynihan R, Cassels A. Selling sickness: how the world’s biggest pharmaceutical companies are turning us all into patients. Nation Books, New York 2005.
  24. Tiefer L. Female sexual dysfunction: a case study of disease mongering and activist resistance. PLoS Med 2006; 3: e178.
  25. Bachkangi P, Salman M. Complications of mid-urethral tape insertion. J Clin Gynecol Obstet 2019; 8: 1-6.
  26. National Institute for Health and Care Excellence. Urinary incontinence and pelvic organ prolapse in women: management. NICE guideline NG123. NICE, London 2019.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Share
without publication fees